Written by Klarity Editorial Team
Published: Jul 14, 2026

Last updated: July 14, 2026
Attention-deficit/hyperactivity disorder (ADHD) affects an estimated 4–5% of adults and up to 10% of school-age children in Idaho. Accessing consistent diagnosis, therapy, and medication management can be challenging without insurance support. If you have Aetna coverage in Idaho, understanding exactly what your plan may cover — and how CVS Caremark, Aetna’s pharmacy benefit manager, handles ADHD medications — can help you make informed decisions before your first appointment.
Wondering if your Aetna plan in Idaho may cover ADHD treatment? Explore ADHD treatment options at Klarity Health and connect with a licensed provider who accepts Aetna.
Aetna in Idaho — offered through Aetna Health of Utah Inc. and Aetna Life Insurance Company — typically covers ADHD treatment as part of its behavioral health benefits on fully insured commercial plans. Covered services may include:
Coverage specifics depend on your Aetna plan type (HMO, PPO, or EPO), your in-network versus out-of-network benefit tier, and your specific employer or individual plan design. Self-funded employer plans governed by ERISA may follow different coverage rules than fully insured Aetna commercial plans.
Idaho’s mental health parity statute — Idaho Code § 41-3901 et seq. — requires fully insured commercial health plans to provide mental health and substance use disorder benefits at parity with medical and surgical benefits. ADHD falls within the scope of mental health benefits under this framework, meaning Aetna’s fully insured plans in Idaho generally may not impose more restrictive treatment limitations on ADHD care than they impose on comparable medical conditions.
This parity protection applies to:
Federal Mental Health Parity and Addiction Equity Act (MHPAEA) protections layer on top of Idaho state law. Self-funded employer plans are subject to MHPAEA federally but are typically exempt from Idaho state parity statutes under ERISA preemption. If you have coverage through a large employer, review your Summary Plan Description (SPD) or contact Aetna directly to confirm which parity protections apply.
Aetna uses CVS Caremark as its pharmacy benefit manager for most commercial plans. Below is a general overview of how common ADHD medications are typically tiered on CVS Caremark commercial formularies. Because individual plan designs vary, always confirm your specific medication’s tier and any prior authorization requirements through your Aetna member portal or by calling CVS Caremark at 1-800-552-8159.
| Medication | Type | Typical CVS Caremark Tier | Prior Auth / Notes |
|---|---|---|---|
| Amphetamine salts (generic Adderall) | Stimulant — Schedule II | Tier 1–2 | Usually no PA; quantity limits may apply |
| Amphetamine salts XR (generic Adderall XR) | Stimulant — Schedule II | Tier 1–2 | Usually no PA; quantity limits may apply |
| Methylphenidate (generic Ritalin) | Stimulant — Schedule II | Tier 1–2 | Usually no PA; quantity limits may apply |
| Methylphenidate ER (generic Concerta) | Stimulant — Schedule II | Tier 1–2 | Usually no PA; quantity limits may apply |
| Lisdexamfetamine (generic Vyvanse) | Stimulant — Schedule II | Tier 2–3 | PA may apply; availability varies — verify with plan |
| Adderall XR (brand) | Stimulant — Schedule II | Tier 3–4 | PA + step therapy (generic required first) |
| Vyvanse (brand lisdexamfetamine) | Stimulant — Schedule II | Tier 3–4 | PA + step therapy; generic now available |
| Concerta (brand methylphenidate ER) | Stimulant — Schedule II | Tier 3–4 | PA + step therapy (generic required first) |
| Mydayis (amphetamine salts ER triple-bead) | Stimulant — Schedule II | Tier 3–4 | PA required; brand-only |
| Atomoxetine (generic Strattera) | Non-stimulant — non-controlled | Tier 1–2 | Usually no PA |
| Strattera (brand atomoxetine) | Non-stimulant — non-controlled | Tier 3–4 | PA; generic atomoxetine preferred |
| Guanfacine ER (generic Intuniv) | Non-stimulant — non-controlled | Tier 1–2 | Usually no PA |
| Clonidine ER (generic Kapvay) | Non-stimulant — non-controlled | Tier 1–2 | Usually no PA |
| Qelbree (viloxazine) | Non-stimulant — non-controlled | Tier 3–4 | PA required; brand-only |
| Jornay PM (methylphenidate HCl ER) | Stimulant — Schedule II | Tier 3–4 | PA required; brand-only |
Note on generic lisdexamfetamine (generic Vyvanse): A generic version of lisdexamfetamine became commercially available in 2023. Formulary placement varies across plan years and plan types. Some CVS Caremark plans have placed generic lisdexamfetamine at Tier 2–3 with potential prior authorization requirements, while others may treat it more favorably. Always verify your specific plan’s tier placement before filling this medication.
Idaho Code § 37-2726A requires that Schedule II controlled substances — which include all ADHD stimulant medications — be prescribed electronically through a certified electronic prescribing system. This is known as EPCS (Electronic Prescribing of Controlled Substances).
What this means for Aetna members seeking ADHD medication in Idaho:
EPCS requirements do not affect whether Aetna or CVS Caremark covers a medication — they govern how the prescription is transmitted. Klarity Health’s platform complies with EPCS requirements for Idaho patients.
Prior authorization (PA) is a process your prescriber must complete before CVS Caremark will cover certain ADHD medications. Brand-name stimulants and newer formulations typically require PA on CVS Caremark formularies. Step therapy — requiring a trial of a generic or preferred medication before a brand-name drug is covered — is also common.
Typical PA timelines for Aetna/CVS Caremark ADHD medications:
To initiate a prior authorization for an ADHD medication, your Klarity Health provider will submit documentation to CVS Caremark on your behalf. Documentation typically includes your ADHD diagnosis, previous medications tried and failed, clinical notes supporting medical necessity, and dosing rationale.
ADHD treatment often involves more than medication. Aetna’s behavioral health benefits in Idaho may cover a range of non-medication services:
Aetna HMO members in Idaho generally require a referral from their primary care provider to access specialist mental health services. Aetna PPO and EPO members typically have direct access to in-network behavioral health providers without a referral. Always confirm your plan’s referral requirements before scheduling an evaluation or therapy appointment.
Telehealth has expanded significantly as an access point for ADHD diagnosis and management. Aetna’s commercial plans in Idaho typically cover telehealth visits for behavioral health at parity with in-person visits, consistent with federal telehealth parity guidance and Idaho’s evolving telehealth coverage framework.
For telehealth ADHD care, this may include:
Telehealth providers prescribing Schedule II ADHD stimulants to Idaho patients must comply with EPCS requirements under Idaho Code § 37-2726A, as noted above. The federal Ryan Haight Act’s in-person evaluation requirement for controlled substance prescribing via telehealth was modified by DEA interim rules; check with your telehealth provider for the most current prescribing requirements.
Klarity Health connects patients in Idaho with 2,000+ licensed providers across psychiatry, primary care, and behavioral health. Many Klarity providers may accept Aetna insurance plans, and the platform is designed to make ADHD evaluation, diagnosis, and ongoing medication management accessible via telehealth.
Klarity’s platform complies with Idaho’s EPCS requirements for Schedule II stimulant prescriptions, so patients receiving ADHD stimulant medications through Klarity can have prescriptions transmitted electronically to their pharmacy of choice, including CVS Caremark-network pharmacies.
Ready to explore ADHD care? See ADHD treatment options at Klarity Health — licensed providers, telehealth appointments, and insurance-informed care in Idaho.
Aetna’s fully insured commercial plans in Idaho typically cover ADHD diagnostic evaluations as a mental health benefit, subject to Idaho’s parity law (Idaho Code § 41-3901 et seq.) and MHPAEA. Coverage for neuropsychological testing may require prior authorization. Self-funded employer plans may have different evaluation coverage — check your SPD or call Aetna at 1-800-872-3862 to confirm.
Generic lisdexamfetamine (the generic form of Vyvanse) became available in 2023 and has been added to many CVS Caremark commercial formularies. However, tier placement varies by plan design — some plans list it at Tier 2–3 with potential prior authorization, while others may require a trial of other generic stimulants first. Always verify your specific plan’s coverage for generic lisdexamfetamine through your Aetna member portal or by calling CVS Caremark at 1-800-552-8159 before filling the prescription.
Idaho Code § 37-2726A requires Electronic Prescribing of Controlled Substances (EPCS) for Schedule II medications, which include all ADHD stimulants (amphetamine salts, methylphenidate, lisdexamfetamine, and related formulations). Your prescriber — whether in-person or via telehealth — must transmit your stimulant prescription electronically through a certified EPCS platform directly to your pharmacy. Paper or phoned-in prescriptions for Schedule II stimulants are generally not accepted in Idaho under this requirement.
Yes. If CVS Caremark denies prior authorization for an ADHD medication, you have the right to appeal. Your prescriber can submit a peer-to-peer review request within the standard review period. If the internal appeal is denied, fully insured Aetna plans in Idaho must offer access to external independent review. You may also contact the Idaho Department of Insurance at 1-800-721-3272 to file a complaint if you believe the denial violates Idaho’s mental health parity law.
It depends on your Aetna plan type. HMO members in Idaho typically need a referral from their primary care provider to see a psychiatrist or behavioral health specialist for ADHD. PPO and EPO members generally have direct access to in-network behavioral health providers without a referral. Check your Aetna member card, Summary of Benefits and Coverage, or call Aetna Member Services at 1-800-872-3862 to confirm your plan’s referral rules.
Disclaimer: This article is for general informational purposes only and does not constitute insurance, legal, or medical advice. Coverage for ADHD treatment varies by Aetna plan type, employer contract, and individual benefit design. Always verify your specific benefits with Aetna and CVS Caremark before scheduling appointments or filling prescriptions. Self-funded employer plans under ERISA may be exempt from Idaho state parity requirements. For questions about your rights, contact the Idaho Department of Insurance at 1-800-721-3272.
Find the right provider for your needs — select your state to find expert care near you.